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Splice site selection is a key element of pre-mRNA splicing. Although it is known to involve specific recognition of short
consensus sequences by the splicing machinery, the mechanisms by which 59 splice sites are accurately identified
remain controversial and incompletely resolved. The human F7 gene contains in its seventh intron (IVS7) a 37-bp VNTR
minisatellite whose first element spans the exon7–IVS7 boundary. As a consequence, the IVS7 authentic donor splice
site is followed by several cryptic splice sites identical in sequence, referred to as 59 pseudo-sites, which normally
remain silent. This region, therefore, provides a remarkable model to decipher the mechanism underlying 59 splice site
selection in mammals. We previously suggested a model for splice site selection that, in the presence of consecutive
splice consensus sequences, would stimulate exclusively the selection of the most upstream 59 splice site, rather than
repressing the 39 following pseudo-sites. In the present study, we provide experimental support to this hypothesis by
using a mutational approach involving a panel of 50 mutant and wild-type F7 constructs expressed in various cell
types. We demonstrate that the F7 IVS7 59 pseudo-sites are functional, but do not compete with the authentic donor
splice site. Moreover, we show that the selection of the 59 splice site follows a scanning-type mechanism, precluding
competition with other functional 59 pseudo-sites available on immediate sequence context downstream of the
activated one. In addition, 59 pseudo-sites with an increased complementarity to U1snRNA up to 91% do not compete
with the identified scanning mechanism. Altogether, these findings, which unveil a cell type–independent 59 39-
oriented scanning process for accurate recognition of the authentic 59 splice site, reconciliate apparently contradictory
observations by establishing a hierarchy of competitiveness among the determinants involved in 59 splice site
selection.
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Introduction
A problem in mammalian pre-mRNA splicing is decipher-
ing the mechanisms underlying the recognition of authentic
signals for proper splicing. The accurate recognition of exons
is a process that requires assembly of the major spliceosome,
a macromolecular machinery that involves the coordinated
action of small nuclear RNAs (snRNAs) and more than 100
polypeptides [1,2]. Any abnormality in that process will
generate aberrant mRNAs that are either unstable or code for
defective and/or deleterious protein isoforms [3]. As a
puzzling paradox, in higher eukaryotes, introns are essentially
deﬁned by three short and poorly conserved sequences: the 59
splice site, the branch point, and the 39 splice site [4,5].
Moreover, as splice site consensus motifs are degenerated,
within a typical mammalian transcript, several sequences, in
addition to the authentic splicing elements, referred to as
pseudo-sites, may match the consensus splice site signals, and
sometimes even better than the real splice sites. These
elements deﬁne a set of pseudo-exons that greatly outnumber
genuine exons, but that are normally not included in mature
mRNAs [6].
A number of structural features has been shown to play a
key role in 59 splice site selection [7]. One of them is the splice
site sequence itself. The 59 splice site consensus sequence
comprises nine partially conserved nucleotides at the exon–
intron boundary: MAG/guragu (with M and r standing for A
or C and a or g, respectively, and / denoting the cleavage site).
This consensus actually reﬂects the base pairing between the
donor splice sequence and the 59 terminus of the U1snRNA,
which is involved in the early steps of splicing [8]. For a given
splice site, the strength of this interaction is usually assessed
by its consensus value (CV) [4]. Besides this interaction,
different sets of auxiliary cis-regulatory elements, known as
splicing enhancers or silencers, contribute to the identiﬁca-
tion of authentic 59 splice sites [1].
The situation may be complicated by the presence, within
several genes, of minisatellites, with their ﬁrst monomer
element spanning an exon–intron boundary. As a conse-
quence, the exact sequence of the splice donor site is
reiterated in the following intron. Such minisatellites provide
an outstanding physiological model to study the mechanisms
underlying splice site selection. However, the resulting
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and demonstrated the activation of only the most and
second-most upstream pseudo-sites. Such is the case for the
second intronic sequence of the human interferon-inducible
6–16 gene, in which the authentic splice donor site is followed
by 25 pseudo-sites, whereas transcript analysis demonstrated
the constitutive utilisation of the two most proximal pseudo-
sites in addition to the authentic one [9]. Two pseudo-sites
are also utilised in addition to the authentic splice donor site
in the human CBS gene, encoding the cystathionine beta-
synthase, that contains a minisatellite in intron (IVS) 13 with
15 20 monomer repeats[10,11]. In the human LAMIN B2
gene, which contains a minisatellite consisting of 10 15
repeats of a 100-bp monomer, only the authentic splice donor
site is used [12]; a similar situation has been observed in the
PDGF gene that contains 16 18 repeats of an 81-bp monomer
element in intron 4 [13]. In all these cases, the mechanism
precluding the use of pseudo-sites has not been investigated.
Like the above-mentioned genes, the F7 gene (GENBANK
access: NM_000131), which encodes FVII (zymogen of a
blood coagulation serine protease), displays a peculiar
organization with a minisatellite located within IVS7 [14].
In IVS7, the ﬁrst 37-bp monomer element consists of the last
four bp of exon 7 and the ﬁrst 33 bp of IVS7 [15]. This
minisatellite is polymorphic, with at least ﬁve different alleles
containing ﬁve to nine repeats of this 37-bp monomer ([16–
19]). The IVS7 59 authentic donor splice site UGG/gugggu
(where / represents the cleavage site) is, therefore, followed by
four to eight copies of 59 pseudo-splice sites that are strictly
identical in sequence; however, strikingly, in physiological
conditions, only the most upstream 59 splice site is used [15].
The study of F7 pre-mRNA splicing thus provides an
opportunity to assess the mechanism underlying 59 splice
site selection for transcripts of particular clinical importance,
as judged by the potentially severe phenotype of patients with
inherited FVII deﬁciency [20].
In previous work, we investigated the functional conse-
quences of a transversion located within the authentic IVS7
splice donor site of the F7 gene from a patient with severe
FVII deﬁciency [21]. We showed that the mutation resulted in
the activation of a single cryptic site corresponding to the 59
pseudo-site located in the second IVS7 minisatellite mono-
mer repeat. This observation led us to propose the existence
of a physiological mechanism that, in the presence of
consecutive splice consensus sequences, would exclusively
stimulate and select the most upstream 59 splice site, rather
than repress the 39 following pseudo-site(s) [21]. This model
prompted us to investigate the mechanism underlying the
accurate selection and activation of one particular 59 splice
donor site among ﬁve identical sites. In the present study, we
address this issue using a mutational approach. Our ﬁndings
unveil a nuclear 59 39-oriented scanning mechanism as the
leading part of the splicing machinery, which is not cell type–
dependent.
Results
F7 IVS7 59 Pseudo-Sites Are Potentially Functional, but Do
Not Compete with the Authentic Donor Splice Site:
Evidence for a Scanning Process in 59 Splice Site Selection
To test whether each of the ﬁve IVS7 59 pseudo-sites are
potentially functional, in addition to the mutant minigene
carrying the mutation identiﬁed in our patient with severe
FVII deﬁciency and the wild-type construct (pF7m and pF7wt,
Figures 1 and 2A), we generated ﬁve constructs (designated
pF7m1 to pF7m5, see Materials and Methods and Figure 2A),
with sequential inactivation of one to ﬁve pseudo-sites. RT-
PCR ampliﬁcation of F7 transcripts isolated from Chinese
hamster ovarian (CHO) cells transfected with the wild-type
minigene yielded a 842-bp amplicon resulting from normal
splicing of the entire IVS7 (Figure 2B, lane 1). This result,
Figure 1. Schematic Representation of the Human F7 Gene and Wild-
Type and Mutant F7 Minigenes Cloned into pTracer-CMV Vector
Sizes of exons (E, open boxes) and introns (I, horizontal lines) are
indicated. Primers Pa, Pb, Pe, Ph, and Pm are represented by horizontal
arrows indicating their respective positions in the minigene sequence.
Inset indicates the last three nucleotides of exon 7 (capital letters) and
the first ten nucleotides of IVS7 (in lowercase characters) of the wild-type
F7 gene. The invariant gt dinucleotide is indicated in underlined bold
letters. A vertical arrow indicates the nucleotide change in the mutant
sequence.
DOI: 10.1371/journal.pgen.0020138.g001
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Synopsis
Typically, mammalian genes contain coding sequences (exons)
separated by non-coding sequences (introns). Introns are removed
during pre-mRNA splicing. The accurate recognition of introns
during splicing is essential, as any abnormality in that process will
generate abnormal mRNAs that can cause diseases. Understanding
the mechanisms of accurate splice site selection is of prime interest
to life scientists. Exon–intron borders (splice sites) are defined by
short sequences that are poorly conserved. The strength of any
splice sequence can be assessed by its degree of homology with a
splice site consensus sequence. Within exons and introns, several
sequences can match with this consensus as well as or better than
the splice sites. Using a system in which a splice site sequence is
repeated several times in the intron, the authors showed that linear
59 39 search is a leading mechanism underlying splice site selection.
This scanning mechanism is cell type–independent, and only the
most upstream splice site of all the series is selected, even if splice
sites with a better match to the consensus are in the vicinity. These
findings reconciliate contradictory observations and establish a
hierarchy among the determinants involved in splice site selection.which was obtained with the use of primers Pe and Pm, was
reproduced with other primer sets that ﬂank IVS7 (unpub-
lished data).
By contrast, in similar assays performed with the mutant
constructs pF7m and pF7m1 to pF7m5 (Figure 2B, lanes 2–7),
no normal splicing could be detected. More precisely,
transient transfection of constructs pF7m1 to pF7m4 resulted
in the generation of two kinds of aberrantly spliced products
(Figure 2B, lanes 3–6), one of size that was always slightly
larger than expected. Sequencing of the corresponding RT-
PCR products demonstrated that sequential inactivation of
the 59 pseudo-sites led to the activation of the next, most
upstream functional IVS7 59 pseudo-site available. Such
activation of a cryptic site led to the retention of short
portions of IVS7 in the corresponding mutant cDNA between
exons 7 and 8, accounting for the slight size differences
between the resulting RT-PCR products (Figure 2B); sequenc-
ing of the second aberrantly spliced product, which was
smaller in size than expected, showed that it corresponds to a
unique molecular species lacking the entire exon 7 (exon
skipping), thereby demonstrating that, for those constructs,
the IVS6 donor splice site was utilized in combination with
the IVS7 acceptor splice site. Strikingly, the relative amount
of the two observed splicing products seemed to differ
according to the construct, as shown after ethidium bromide
staining (Figure 2B, lanes 3 to 6). Indeed, although our
approach was not quantitative, the intensity of the larger
products corresponding to the activation of each of the
cryptic sites clearly decreased according to the number of
inactivated pseudo-sites, while concurrently, the intensity of
the smaller product lacking exon 7 increased. In keeping with
these observations, in cells transfected with the pF7m5
construct, in which all pseudo-sites were inactivated, only
the product resulting from exon 7 skipping could be detected
(Figure 2B, lane 7), whereas in cells transfected with the pF7m
construct, in which only the ﬁrst 59 splice site was inactivated,
a single product was identiﬁed, resulting from the activation
of the 59 pseudo-site located in the second 37-bp monomer
element (Figure 2B, lane 2). For all transfection experiments,
examination of 50 additional clones obtained after subclon-
ing of non-puriﬁed RT-PCR products generated with primers
Pe and Pm failed to detect any other splice variants, thereby
indicating that such species, if they indeed exist, are
expressed at extremely low levels.
Altogether, these data show that the ﬁve IVS7 59 pseudo-
sites are potentially functional but do not compete for
splicing with the IVS7 authentic donor splice site. They also
reveal that when several adjacent pseudo-sites are inactivated,
only the most upstream functional IVS7 59 pseudo-site
available is used, suggesting the existence of an accurate
mechanism underlying the selection of the active 59 splice
site.
Selection of the 59 Splice Site Follows a Scanning-Type
Mechanism Precluding Competition with Other Most
Upstream Functional 59 Pseudo-Site Available on
Immediate Sequence Context
To gain insights into the mechanism underlying selection
of the donor splice site, we next generated F7 minigenes
containing functional 59 pseudo-sites, separated by one or
several inactivated 59 splice sites (Figure 3A). As shown in
Figure 3B, RT-PCR ampliﬁcation of the transcripts expressed
by CHO cells transfected with the mutant constructs pF7m6
to pF7m11—in which the ﬁrst pseudo-site was always
mutated—yielded a single band slightly larger in size than
the one obtained with the wild-type construct (lanes 2 to 7); as
shown after sequencing, this larger molecular species results
from activation of the next functional 59 pseudo-site.
To conﬁrm the hypothesis that the most upstream 59 splice
site is selected for splicing, we studied the F7 transcripts
generated from CHO cells transfected with three additional
constructs (pF7m12 to pF7m14) in which the ﬁrst, second,
and fourth pseudo-sites were inactivated in combination with
either the third or the sixth pseudo-site (Figure 3A). As shown
in Figure 3B, PCR ampliﬁcation of the corresponding cDNAs
resulted in the generation of two kinds of aberrantly spliced
products (lanes 8 to 10): one of size always slightly larger than
expected that resulted from the activation of the most
Figure 2. Assessment of the Ability of the IVS7 Pseudo-Sites to Be
Activated
(A) Schematic representation of the constructs used in this experiment.
Top: Organization of the wild-type F7 IVS7 proximal region (pF7wt);
exons and introns are represented by open boxes and thin lines,
respectively. The first 37-bp monomer, which spans the exon7–IVS7
boundary, is repeated within IVS7. The monomers are represented by a
thick grey line. Each pseudo-splice site is represented by a grey box, and
is separated from the next one by 28 bp. Bottom: Schematic
representation of the various F7 minigenes carrying a T-to-A transition
located at the main dinucleotide of the consensus donor splice site and
involving several consecutive 37-bp monomer elements found in IVS7.
Mutations are represented by a black cross.
(B) RT-PCR amplification of F7 transcripts isolated from CHO cells
transfected with the above-mentioned constructs. The products
corresponding to the different PCR fragments, as identified by
sequencing, are schematically represented on both sides of the figure.
DOI: 10.1371/journal.pgen.0020138.g002
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Oriented Scanning for 59 Splice Site Selectionupstream functional IVS7 59 pseudo-site, and an additional
band, smaller in size, that corresponded to a species in which
exon 7 was skipped. Again, when two splice products were
observed, their relative proportions seemed to differ accord-
ing to the position of the available functional 59 pseudo-site.
Taken together, these results are consistent with a
scanning-type process of selection of the 59 splice site, which
precludes competition with other more downstream func-
tional 59 pseudo-sites. Indeed, other splicing mechanisms
would predict the use of the ﬁrst functional 59 pseudo-sites
downstream of the inactivated splice site, whereas such a
scanning model predicts predominant use of the ﬁrst
available 59 splice site.
The Identified Scanning Mechanism for 59 Splice Site
Selection Is Not Cell Type–Dependent
The above-described experiments were performed in CHO
cells. To test whether the identiﬁed scanning process is cell
type–dependent, we performed similar studies in COS-7 and
HeLa cells with F7 minigenes that, when transfected in CHO
cells, gave representative RT-PCR patterns: pF7ma n d
pF7m10 that were associated with the use of the most
upstream functional 59 pseudo-site available (Figure 2B, lane
2, and Figure 3B, lane 6); pF7m12, associated with the same
splicing event and exon skipping (Figure 3B, lane 8); and
pF7m5 that was associated with exon skipping only (Figure
2B, lane 7). As shown in Figure 4, transfection of these
minigenes in COS-7 and HeLa cells led to splicing patterns
similar to those observed in CHO cells. These results provide
evidence for a scanning mechanism that is not cell type–
dependent, and, therefore, strongly suggest that the machi-
nery involved in 59 splice site selection is ubiquitous.
59 Pseudo-Sites with a CV as High as 91 Do Not Compete
with the Identified Scanning Process
The wild-type 59 splice donor site sequence of IVS7 of the
human F7 gene (TGG/gtgggt), like each of the ﬁve 59 pseudo-
sites, offers a reasonable agreement with the consensus
sequence of the splice donor sites, with a CV of 74 (Figure
5A), as assessed according to Shapiro and Senapathy [4]. To
test whether 59 pseudo-sites with higher CVs could compete
with the identiﬁed scanning process, we transfected CHO
cells with a series of F7 minigenes carrying different
Figure 3. Splice Site Selection in the Context of Functional 59 Pseudo-
Sites, Separated by One or Several Inactivated 59 Splice Sites
(A) Schematic representation of the constructs used in this experiment
(see legend to Figure 2A for the meaning of each symbol).
(B) RT-PCR amplification of F7 transcripts isolated from CHO cells
transfected with the above-mentioned constructs. The products
corresponding to the different PCR fragments, as identified by
sequencing, are schematically represented on both sides of the figure.
DOI: 10.1371/journal.pgen.0020138.g003
Figure 4. The Identified Scanning Mechanism for Splice Site Selection Is
Not Cell Type–Dependent
(A) Schematic representation of the constructs used in this experiment
(see legend to Figure 2A for the meaning of each symbol).
(B) RT-PCR amplification of F7 transcripts isolated from COS-7 and HeLa
cells transfected with the above-mentioned constructs. The products
corresponding to the different PCR fragments, as identified by
sequencing, are schematically represented on both sides of the figure.
DOI: 10.1371/journal.pgen.0020138.g004
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Oriented Scanning for 59 Splice Site Selectioncombinations of 59 pseudo-sites with increased CV on a
pF7wt or a pF7m background (Figures 5 and 6). The following
mutations were introduced in order to increase the com-
plementarity of the resulting transcripts with the 59 end of
the U1snRNA sequence: a G-to-A transition at position 2o r
þ3 of the TGG/gtgggt splice site (i.e., TAG/gtgggt or TGG/
gtaggt with a CV of 82.2 or 85, respectively; see Figure 5A,
top), and a G-to-A transition at positionþ4 of the TGG/gtgggt
splice site (i.e., TGG/gtgagt with a CV of 91; see Figure 5B,
top). As shown in Figure 5A and 5B (bottom), the PCR
products generated from each construct demonstrated the
exclusive use of the most upstream functional 59 site,
regardless of its CV (i.e., 74, 82.2, 85, or 91). These results
were conﬁrmed by subcloning and subsequent sequencing of
the non-puriﬁed RT-PCR products.
We next tested whether the most upstream functional 59
site is still used when it is followed by sequences matching a
perfect splice donor site. To this end, we designed mutant F7
minigenes carrying the following mutations that were
introduced in the splice site sequences in order to match
perfectly with the 59 end of the U1snRNA sequence, in the
context of pF7wt: a T-to-C transition at position 3, a G-to-A
transition at position  2, and a G-to-A transition at position
þ4 of the TGG/gtgggt splice site (i.e., CAG/gtgagt with a CV of
100; see Figure 6, top). As shown in Figure 6 (bottom), two
molecular species were generated from these latest con-
structs. Although noteworthy, with such constructs one would
expect the exclusive use of the perfect sites; this experiment
and the subsequent sequencing of those products showed that
the optimal splice sequences were used with an efﬁciency of
approximately 70% (pF7wt_100–1) and 90% (pF7wt_100–
2), thereby demonstrating that the most upstream 59 site is
always used, even in the presence of a perfect splice site.
Taken together, these results show ﬁrstly that, even when
the CV is as high as 91%, the 59 pseudo-sites do not compete
with the identiﬁed scanning process. Secondly, competition
occurs only when those sequences match a perfect consensus
(CV of 100), and even in that case, the scanning process is still
active, as demonstrated by the use of the most upstream
functional 59 site.
No Autonomous Regulating Element Lies in the
Neighbouring Intronic Sequence
Intronic splice enhancer sequences, when placed between
competing 59 splice sites, have been shown to favour the use
of the upstream, most distal, 59 splice site [22,23]; we,
therefore, hypothesized that an intronic regulatory element,
which could overlap one or several 37-bp monomer repeats,
may either prevent the use of pseudo-sites or stimulate the
use of the most upstream one. To test this hypothesis, we
performed sequential deletions of the 37-bp monomer
repeats of pF7wt and/or pF7m; the resulting constructs
carrying one to six monomer repeats are shown in Figure
7A (top). As shown in Figure 7A (bottom), such truncations
did not change the splicing pattern observed with the pF7wt-
and the pF7m-derived constructs, suggesting that the deleted
regions did not contain any regulatory element.
Similarly, we designed F7 expression plasmids with the
insertion, in pF7wt and/or pF7m, of several 37-bp monomer
elements; the resulting constructs carrying eight to 12
monomer repeats are shown in Figure 7B (top). As shown
in Figure 7B (bottom), the choice of the 59 site used for
Figure 5. Splicing of a Series of Mutants with Increased Complementarity
of the IVS7 59 Pseudo-Sites to U1snRNA
(A) Splicing of F7 transcripts generated from F7 minigenes with a CV of
85 or 82.2.
(B) Splicing of F7 transcripts generated from F7 minigenes with a CV of
91.
(A and B) Top: Wild-type (middle line in [A], lower line in [B]) and mutated
(lower and upper lines in [A], upper line in [B]) 59 pseudo-sites in the F7
minigene. Dots show the location of the introduced mutations. Suffixes
of the constructs’ names and the resulting CVs are indicated. Middle:
Schematic representation of the constructs transfected in CHO cells.
Improved splice sites are represented by a hatched square (see legend to
Figure 2A for the meaning of each symbol). Bottom: RT-PCR amplification
of F7 transcripts isolated from CHO cells transfected with the above-
mentioned constructs. The products corresponding to the different PCR
fragments, as identified by sequencing, are schematically represented on
both sides of the figure.
DOI: 10.1371/journal.pgen.0020138.g005
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repeats contained in those constructs; indeed, in all cases only
the most upstream functional site was activated. We therefore
concluded that the neighbouring intronic sequence does not
contain an overlapping regulatory element.
As for the 37-bp monomer repeats themselves, we noticed
that they contain two G triplets that are small sequence
elements known to modulate 59 splice site selection in
mammals [22,23] (see Figure 2A, in bold underlined letters).
To determine if these elements affect 59 splice site selection,
we modiﬁed their sequence, while keeping the CV of the
corresponding 59 splice sites at least equal to the CV of the
wild-type sequence (74): a G-to-T transversion was introduced
at position  2o rþ4 of the TGG/gtgggt splice site (i.e., TTG/
gtgggt or TGG/gtgtgt with a CV of 74.7 or 74.1, respectively;
see Figure 8, bottom and middle). As shown in Figure 8
(bottom), mutations of the identiﬁed G triplets did not
modify the splicing pattern, strongly arguing against their
involvement in the selection of the most upstream 59 splice
site.
The Scanning Process Initiates Downstream of Exonic
Cryptic Sites
The ‘‘exon deﬁnition’’ model—based on the fact that, in
vertebrates, exons are generally much smaller than introns—
assumes that pairing between the splice sites occurs across an
exon through the concerted recognition of the splice sites
ﬂanking this exon (reviewed in [5]). This model predicts that a
mutation involving a 59 splice site would prevent the
recognition of the upstream exon, leading to skipping of this
exon and/or activation of a cryptic site that lies in this exon.
To gain insight into the initiation step of the scanning
process, we ﬁrst looked for potential cryptic donor splice sites
within exon 7 of the F7 gene. As previously reported, a strong
exonic cryptic site is located at IVS7–115, with a CV of 72,
close to the CV of the authentic IVS7 59 splice site sequence
(CV of 74) [21]. We subsequently generated two constructs,
derived from pF7wt and pF7m, in which this exonic cryptic
site TTG/GTGAAT (CV of 72) was mutated toward TAG/
GTGAAT (CV of 85), so that its resulting CV is above that of
the 59 authentic splice site (Figure 9A, top and middle), and
tested whether this improved cryptic site could be selected
for splicing. As shown in Figure 9A (bottom), this point
mutation did not modify the splicing patterns, as compared
with those associated with pF7wt and pF7m, a result that was
conﬁrmed by sequence analysis of the corresponding RT-PCR
products. These results, therefore, support the hypothesis
that, in these experimental conditions, the search for the
active 59 site initiates downstream of this exonic cryptic site.
However, an alternative explanation is the decreased
splicing efﬁciency of unusually small exons: indeed, a 59 splice
site located too close to the 39 splice site may have been
ignored due to the excessively small size of the potential exon
[24]. To test this hypothesis, we chose to work on another
sequence located in exon 7 (CCGCGGC, with a CV of 28%)
that, if selected for splicing, would yield an exon of 70
nucleotides (versus 124 nucleotides in the normal situation).
This size seemed reasonable, since, as demonstrated recently,
the length of abnormal exons that result from cryptic 59 splice
site usage is comprised of between 50 and 250 nucleotides [25].
Wemodiﬁed this sequence in order to generate two additional
mutants harbouring the following potential splice sequences:
CCGGTCGGC, with a CV of 72, very close to the CV of the
authentic splice site (74), and CAGGTAGGC with a CV of 89,
above that of the authentic 59 splice site (Figure 9B, top and
middle). Again, the PCR products generated from all the
constructs and subsequent sequencing demonstrated the
exclusive use of the authentic 59 site (Figure 9B, bottom).
These data strongly argue against an excessively small size of
the potential exon as a structural feature precluding the use of
an exonic cryptic donor splice site. Taken together, these
results further strengthen the hypothesis that the scanning
process initiates downstream of exonic cryptic sites.
Discussion
The human F7 gene, which encodes an essential coagu-
lation factor, provides a remarkable model to decipher the
mechanism underlying 59 splice site selection in mammals.
The ﬁrst 37-bp monomer element of the polymorphic
minisatellite located in IVS7 contains the exon7–IVS7
junction. As a consequence, in the primary transcripts,
several IVS7 59 splice sites (ranging from ﬁve to nine),
identical in sequence, compete to join a single 39 acceptor
site. It is, however, noteworthy that physiologically, only the
most upstream 59 splice site is used, the unused 59 splice sites
being referred to as pseudo-sites. Therefore, IVS7 of the
human F7 gene must rely upon peculiar mechanisms to
accurately control splice site selection. We have previously
proposed a model imparting a strong preference for use of
the most upstream 59 pseudo-site, rather than some repres-
Figure 6. Splicing of a Series of Mutants with IVS7 59 Pseudo-Sites
Perfectly Matching U1snRNA
Top: Wild-type (lower line) and mutated (upper line) 59 pseudo-sites in
the F7 minigene. Dots show the location of the introduced mutations.
Suffix of the constructs’ names and the resulting CV of 100 are indicated.
Middle: Schematic representation of the constructs transfected in CHO
cells. Splice sites matching the consensus are represented by a hatched
square (see legend to Figure 2A for the meaning of each symbol).
Bottom: RT-PCR amplification of F7 transcripts isolated from CHO cells
transfected with the above-mentioned constructs. The products
corresponding to the different PCR fragments, as identified by
sequencing, are schematically represented on both sides of the figure.
DOI: 10.1371/journal.pgen.0020138.g006
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Oriented Scanning for 59 Splice Site Selectionsion of the downstream following ones [21]. The results of the
present study lend strong support to this model. They also
provide several lines of evidence that favour an unbending
scanning model that, in the context of several functional 59
splice sites, would always select the most upstream 59 splice
site through a mechanism that precludes competition with
other functional 59 pseudo-sites.
This study was initiated to test whether the different 59
pseudo-sites located in IVS7 of the F7 gene are functional.
Indeed, although all these sites are identical in sequence to
the authentic one, one cannot exclude the possibility that
they are unused because of a particular sequence context that
could act through different means—such as, for instance, a
secondary structure-dependent mechanism that would mask
these pseudo-sites. We examined the possible secondary
structure elements using different prediction of secondary
structure tools, such as those at http://www.genebee.msu.su/
services/rna2_reduced.html and http://www.bioinfo.rpi.edu/
applications/mfold/rna/form1.cgi.
However, we did not show any arrangement speciﬁc to the
sequence surrounding the pseudo-sites, which could explain
the splicing phenotype observed in our study. Previous
studies suggested that the 59 splice sites whose activation
would lead to a premature stop codon are not used so that an
open reading frame is maintained [26,27]. Nevertheless, in
our system, such a mechanism would predict the alternative
use, in addition to the authentic 59 splice site, of the ﬁfth and
sixth 59 pseudo-sites that do not lead to a premature stop
codon (unpublished data); as shown here, however, this is not
the case. An alternative explanation accounting for the non-
utilisation of the 59 pseudo-sites is that, as suggested by others
[22,23,28], they reside in a sequence context that hampers
their utilisation. We could, however, exclude the involvement
of intronic cis-acting auxiliary sequences in the splice site
selection. Our data, which demonstrate that all 59 pseudo-
sites can be efﬁciently activated, argue against this hypothesis
and rather suggest that these sites, though functional, are
physiologically unused because of a competition-based
mechanism. As shown here, the major determinant of this
mechanism would be the location of these sites relative to
each other: the more upstream intronic functional donor
splice site is much more competitive and is actually the only
one to be selected for splicing. These results strongly suggest
a mechanism of oriented linear search for the selection of the
59 splice site, starting upstream of the intervening sequence.
Indeed, alternative modes of scanning processes would
predict the use of other 59 splice sites downstream.
The strength of this model is attested to by the fact that 59
pseudo-sites with a CV as high as 91 still do not compete with
the most upstream functional site, since they are not used for
splicing, even at low efﬁciency. And only 59 pseudo-sites with
aC Vo f1 0 0 ,h e n c ep e r f e c t l ym a t c h i n gt h ec o n s e n s u s
sequence, can shift splicing toward their use, even though
they still do not preclude the use of the most upstream
functional site with a much lower CV. In this regard, it is
important to underline that the optimal splice sequences are
extremely rare in human genes. A compilation of authentic
Figure 7. Search for Putative Intronic Sequences Regulating Splice Site
Recognition
(A) Top: Schematic representation of the constructs used in this
experiment with deletions involving one or several 37-bp monomers in
the context of pF7wt or pF7m (see legend to Figure 2A for the meaning
of each symbol). Bottom: RT-PCR amplification of F7 transcripts isolated
from CHO cells transfected with the above-mentioned constructs. The
products corresponding to the different PCR fragments, as identified by
sequencing, are schematically represented on both sides of the figure.
(B) Top: Schematic representation of the constructs used in this
experiment with insertions of several 37-bp monomers in the context
of pF7wt or pF7m (see legend to Figure 2A for the meaning of each
symbol). Bottom: RT-PCR amplification of F7 transcripts isolated from
CHO cells transfected with the above-mentioned constructs. The
products corresponding to the different PCR fragments, as identified
by sequencing, are schematically represented on both sides of the figure.
DOI: 10.1371/journal.pgen.0020138.g007
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CV of authentic splice sites was 82.96 6 6% [25], which is not
only far below the optimal homology (CV of 100%), but also
below the CV of pseudo-sites that we showed to be unable to
compete with the most upstream 59 splice. Moreover, a recent
comparative analysis of human donor splice sequences
showed that of 45,519 genes, only 2,360 contained a CV of
90% [29]. The low frequency of donor splice sequences
perfectly matching the consensus could be explained by the
fact that, as shown in Saccharomyces cerevisiae [30], hyper-
stabilization of the spliceosome (with more than seven
potential Watson–Crick base pairs to U1snRNA) would
inhibit the splicing process [31,32].
Our observations raise the larger question of the mecha-
nism by which the most upstream functional site is recognised
by the splicing machinery. In other words, what are the
determinants involved in the initial step of such an oriented
scanning process? This question is still open, although, in the
case of F7, we could show that the increase of the CV of the
exonic cryptic sites failed to induce their activation, thereby
implying that scanning initiates downstream of these sites.
Other data presented here, however, indicate that the extent
to which the orientated scanning process is activated is
distance-dependent: the further away the most upstream
Figure 9. Effect on the Splice Site Selection of Exon 7 Sequences with
Increased Complementarity to U1snRNA
(A) Splicing of F7 transcripts generated from F7 minigenes harbouring an
exonic cryptic site at  113 with a CV of 85.
(B) Splicing of F7 transcripts generated from F7 minigenes harbouring an
exonic cryptic site at  54 with a CV of 72 or 89.
(A and B) Top: Wild-type (lower line in [A], middle line in [B]) and mutated
(upper lines in [A], lower and upper line in [B]) 59 pseudo-sites in the F7
minigene. Dots show the location of the introduced mutations. Suffixes
of the constructs’ names and the resulting CVs are indicated. Middle:
Schematic representation of the constructs transfected in CHO cells.
Improved splice sites are represented by a hatched square (see legend to
Figure 2A for the meaning of each symbol). Bottom: RT-PCR amplification
of F7 transcripts isolated from CHO cells transfected with the above-
mentioned constructs. The products corresponding to the different PCR
fragments, as identified by sequencing, are schematically represented on
both sides of the figure.
DOI: 10.1371/journal.pgen.0020138.g009
Figure 8. Role of G Triplets in IVS7 Splice Site Recognition
Top: Wild-type (middle line) and mutated (lower and upper lines) 59
pseudo-sites in the F7 minigene. Dots show the location of the
introduced mutations. Suffixes of the constructs’ names and the
resulting CVs are indicated. Middle: Schematic representation of the
constructs transfected in CHO cells. Mutated splice sites are represented
by a hatched box (see legend to Figure 2A for the meaning of each
symbol). Bottom: RT-PCR amplification of F7 transcripts isolated from
CHO cells transfected with the above-mentioned constructs. The
products corresponding to the different PCR fragments, as identified
by sequencing, are schematically represented on both sides of the figure.
DOI: 10.1371/journal.pgen.0020138.g008
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more the IVS6 donor splice site is activated, leading to exon 7
skipping. These data, therefore, suggest that the identiﬁed
oriented scanning process, even if predominant, is not
exclusive. In this regard, other mechanisms such as those
underlying exon deﬁnition [5], or those showing a decreased
splicing efﬁciency of exons that are unusually large [33] or
small [24], may also be involved in a balance that, in turn,
favors one or the other 59 splice site that ﬂanks the deﬁned
exon, according to the distance in between these two sites.
Although a scanning process is widely accepted as an
important mechanism for the selection of 39 splice sites [34–
39], none has gained general acceptance for the selection of
the 59 splice sites. Pioneering studies were performed using a
model in which tandem duplications of the donor or
acceptor RNA splice sites of the second intervening sequence
were introduced in the human G gamma-globin gene. The
transcript analysis demonstrated that splicing occurred only
at the proximal copy of the duplicated splice sites [40,41].
From these results, in the presence of only two competing
splice sites, a scanning model for splice site selection was
proposed, but this model was still a matter of debate because
a similar study performed by another group yielded opposite
results [42]. The exon deﬁnition model also involves a
scanning process; however, this one starts at the 39 end of
the upstream intron [5], and elements of the splicing complex
then progressively scan the sequence downstream through
the adjacent exon to locate a suitable 59 splice consensus
sequence. This model, therefore, predicts that a 59 splice site
mutation will lead either to the skipping of the exon
upstream of the mutated 59 splice site, or to activation of
an exonic cryptic splice site that corresponds to the ﬁrst
suitable 59 consensus sequence encountered by the spliceo-
some. Our data partly integrate the splicing patterns
predicted by the exon deﬁnition model: as predicted by this
model, we observed the skipping of exon 7 at different
efﬁciencies for the constructs carrying consecutive inactiva-
tions of the more upstream pseudo-sites. However, they also
diverge from this model in that activation of the strongest
exonic cryptic donor splice site—as predicted by the exon
deﬁnition model—was never observed, even when the CV of
this cryptic site was increased, bringing further complexity to
the characteristics of this mechanism. Finally, similar experi-
ments performed in cells originating from different types
and species, such as CHO, COS-7, and HeLa cells, gave rise to
the same splicing patterns, providing evidence that the
herein identiﬁed oriented scanning mechanism that occurs
within this unusually arranged region does not require any
cell-speciﬁc factor, but rather relies on the constitutive
splicing machinery.
In summary, our results strongly suggest that, in the
presence of consecutive potential splice sites in the neigh-
bouring sequence, unbending scanning will rule the selection
of the activated 59 splice site. In the absence of such
sequences, according to the above-mentioned studies, the
selection of the activated splice site seems to rely upon its
strength—i.e., its complementarity to U1snRNA. Taken
together, our data reconciliate apparently contradictory
observations in the mechanisms of 59 splice site recognition
in mammals by establishing a hierarchy of competitiveness
among the determinants involved in this process.
Materials and Methods
Plasmid constructs. A 3.5-kb F7 genomic region spanning intron 4
to exon 8 (nt7688–11188) was ampliﬁed from a normal individual and
from the FVII-deﬁcient patient identiﬁed previously who carried a
homozygous mutation (9726T.G) in IVS7 [21] The PCR ampliﬁcation
was performed with primers Pa and Pm (Figure 1) using the Expand
high-ﬁdelity PCR system (Boehringer Mannheim, Mannheim, Ger-
many) according to the manufacturer’s recommendations. Both the
wild-type and the mutant F7 allele carried the six repeats of the 37-bp
monomer element (b allele, unpublished data). The wild-type and
mutant PCR fragments were cloned into the cytomegalovirus (CMV)
promoter-based expression vector pTracer (Invitrogen, Carlsbad,
California, United States) using the T4 DNA ligase (Invitrogen)
according to standard procedures; the resulting constructs were
designated pF7wt and pF7m, respectively.
These two expression plasmids were used as templates to generate
48 different constructs by site-directed mutagenesis using the
QuickChange system (Stratagene, Amsterdam, Netherlands). The
characteristics of the resulting plasmids are: the ﬁrst series consists
of 14 constructs—designated pF7m1 to pF7m14 (Figures 2 and 3)—
carrying a T-to-A transition located at the main dinucleotide of the
consensus donor splice site and involving several of the 37-bp
monomer elements found in IVS7.
The second series of expression plasmids consists of 15 constructs:
pF7wt_ 2G.Am1 to pF7wt_ 2G.Am4, pF7wt_þ3G.Am1 and
pF7wt_þ3G.Am2, pF7wt_þ4G.Am1 and pF7wt_þ4G.Am2, and
pF7wt_CV100–1 and pF7wt_CV100–2, which have been designed in
order to improve the CV of one or several pseudo-sites in the context
of pF7wt; and pF7m_ 2G.Am5 and pF7m_ 2G.Am6, and
pF7m_þ3G.Am3 to pF7m_þ3G.Am5, which have been designed
in order to improve the CV of one or several pseudo-sites in the
context of pF7m (Figures 5 and 6).
The third series consists of 14 constructs (Figure 7): pF7wt_del1 to
pF7wt_del5, which have been generated from pF7wt and carry a
targeted deletion involving one to ﬁve of the 37-bp monomer
elements found in IVS7, respectively. Similar deletions involving
three or four of these monomer elements were generated from a
pF7m background, thereby resulting in two expression plasmids
designated pF7m_del3 and pF7m_del4. Constructs were also
generated with insertion of a variable number of the 37-bp monomer
element, either on a pF7wt background (i.e., pF7wt_ins2 to
pF7wt_ins5) or from pF7m (i.e., pF7mins3 and pF7mins5).
The fourth series consists of ﬁve expression plasmids, which were
designed to assess the functional importance of G triplets on splicing,
were generated from pF7wt or pF7m and (Figure 8): pF7wt_ 2G.T,
pF7wt_þ4G.Tm1, pF7wt_þ4G.Tm2, pF7m_–2G.T, and
pF7m_þ4G.T.
The two following site-directed mutageneses were generated on
pF7wt or pF7m in order to improve the CV (from 74 to 85) of a
cryptic donor splice site located within exon 7 at position  113. The
resulting plasmids were named pF7wt_CV85 and pF7m_CV85. The
last two constructs, pF7wt_CV72 and pF7wt_CV89, have been
designed in order to create a donor splice consensus sequence
located within exon 7 at position  54 (Figure 9).
All primers used in ampliﬁcation and mutagenesis steps are
available on request. All the constructs were checked by sequencing
the inserts and the vector ﬂanking regions.
Cell culture and transfections. CHO cells were grown in ISCOVE
medium (Invitrogen). HeLa cells and COS-7 cells were grown in
DMEM medium. Both media were supplemented with 10% fetal calf
serum (FCS) in a 5% carbon dioxide atmosphere at 37 8C.
Transfections were performed at 60% of conﬂuence by the Lip-
ofectamin method (Invitrogen) in OptiMEM medium with 2 lgo f
each of the various constructs, according to the manufacturer’s
instructions. After 5 h, OptiMEM medium was removed and replaced
by the normal medium supplemented with 10% FCS. Each trans-
fection experiment was repeated at least twice.
RNA isolation and cDNA synthesis. Total RNA was extracted from
the cells 48 h after transfection by using RNAplusTM (Bioprobe
Systems, Montreuil-sous-bois, France) according to manufacturer’s
instructions. Following precipitation, RNA was treated with DNaseI
to remove any contaminating plasmid DNA. First-strand cDNA
synthesis was performed from 5 lg of total RNA, with random
hexamers as primers (Pharmacia) and Superscript II (Invitrogen).
One-tenth of each of the ﬁrst-strand synthesis reaction products was
used in each of the three subsequent PCR reactions with oligonu-
cleotides Pb (59 TCTGTGTGAACGAGAACGGC 39)a n dP mt o
amplify exons 5 to 8, Pe (59 AAGAAATGCCAGCAAACCCC 39) and
Pm to amplify exons 6 to 8, and Ph (59 GGAGCT-
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Oriented Scanning for 59 Splice Site SelectionCAGTTGTGTGGGGG 39) and Pm to amplify exons 7 to 8 (see Figure
1). PCR ampliﬁcations were carried out using Expand high-ﬁdelity
PCR systems (Boehringer-Mannheim) as described above.
Transcript analysis. The PCR-ampliﬁed cDNA fragments were
visualized after separation by electrophoresis on 1% agarose gel and
revelation by ethidium bromide staining. Non-puriﬁed PCR products
obtained in each reaction with the various constructs were subcloned
into the plasmid vector pTOPO-4 (TOPO TA-Cloning, Invitrogen).
For each subcloning experiment, at least 50 independent clones were
sequenced on both strands in order to characterize the transcripts.
CV analysis. The statistical rules from Shapiro and Senapathy [4]
were used to assign a score for the authentic and mutated IVS7 splice
sites and the modiﬁed pseudo-sites, as previously described [21].
Brieﬂy, these scores reﬂect the degree of conservation in different
positions resulting from the alignment of 1,446 59 splice sites of other
genes. The consensus 59 splice site sequence is MAG/guragu and spans
from the position  3 (the third nucleotide from the 39 end of the
upstream exon) to þ6 (the sixth nucleotide in the intron). A score of
100 represents the best match to the consensus, whereas 0 is the
worst.
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